
Fortis Healthcare (FORTIS) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
21.7B
Gross Profit
11.9B
54.99%
Operating Income
3.9B
17.96%
Net Income
2.7B
12.31%
EPS (Diluted)
₹3.45
Balance Sheet Metrics
Total Assets
136.9B
Total Liabilities
45.2B
Shareholders Equity
91.7B
Debt to Equity
0.49
Cash Flow Metrics
Operating Cash Flow
163.5M
Free Cash Flow
-200.4M
Revenue & Profitability Trend
Fortis Healthcare Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 77.2B | 68.4B | 62.1B | 56.4B | 39.6B |
Cost of Goods Sold | 35.4B | 31.6B | 28.4B | 25.2B | 10.4B |
Gross Profit | 41.9B | 36.8B | 33.7B | 31.2B | 29.3B |
Gross Margin % | 54.2% | 53.8% | 54.3% | 55.3% | 73.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 4.8B | 4.0B | 3.6B | 3.0B | 10.1B |
Other Operating Expenses | 7.8B | 7.3B | 7.0B | 6.5B | 5.6B |
Total Operating Expenses | 12.6B | 11.3B | 10.6B | 9.4B | 15.7B |
Operating Income | 11.9B | 9.1B | 7.7B | 7.4B | 966.2M |
Operating Margin % | 15.4% | 13.3% | 12.4% | 13.2% | 2.4% |
Non-Operating Items | |||||
Interest Income | 598.3M | 298.9M | 238.3M | 215.5M | 420.1M |
Interest Expense | 1.5B | 1.1B | 1.1B | 1.3B | 1.5B |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 10.1B | 8.6B | 8.1B | 9.9B | 433.0M |
Income Tax | 2.0B | 2.1B | 1.8B | 2.0B | 994.6M |
Effective Tax Rate % | 19.6% | 24.8% | 22.2% | 20.0% | 229.7% |
Net Income | 8.1B | 6.5B | 6.3B | 7.9B | -561.7M |
Net Margin % | 10.5% | 9.4% | 10.2% | 14.0% | -1.4% |
Key Metrics | |||||
EBITDA | 16.4B | 12.9B | 11.5B | 11.0B | 4.8B |
EPS (Basic) | ₹10.26 | ₹7.93 | ₹7.80 | ₹7.35 | ₹-1.45 |
EPS (Diluted) | ₹10.26 | ₹7.93 | ₹7.80 | ₹7.35 | ₹-1.45 |
Basic Shares Outstanding | 754958148 | 754958148 | 754958148 | 754958148 | 754958148 |
Diluted Shares Outstanding | 754958148 | 754958148 | 754958148 | 754958148 | 754958148 |
Income Statement Trend
Fortis Healthcare Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 1.4B | 2.4B | 1.4B | 1.4B | 2.6B |
Short-term Investments | 3.7B | 3.7B | 2.3B | 2.7B | 1.6B |
Accounts Receivable | 7.1B | 5.6B | 5.1B | 4.4B | 3.9B |
Inventory | 1.2B | 1.1B | 1.2B | 1.2B | 767.6M |
Other Current Assets | 5.4M | 5.4M | 499.2M | 81.5M | 174.3M |
Total Current Assets | 14.7B | 14.2B | 14.1B | 11.3B | 10.4B |
Non-Current Assets | |||||
Property, Plant & Equipment | 22.3B | 18.1B | 14.9B | 13.7B | 12.1B |
Goodwill | 87.7B | 88.0B | 87.2B | 85.9B | 75.1B |
Intangible Assets | 3.8B | 4.1B | 4.4B | 3.4B | 637.8M |
Long-term Investments | 0 | 7.6M | 4.4M | - | - |
Other Non-Current Assets | 2.0K | 2.0K | -2.0M | 769.9M | 550.0M |
Total Non-Current Assets | 122.2B | 118.7B | 110.3B | 107.5B | 101.2B |
Total Assets | 136.9B | 132.9B | 124.3B | 118.8B | 111.5B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 8.1B | 7.3B | 7.1B | 6.6B | 5.5B |
Short-term Debt | 1.6B | 1.7B | 1.7B | 2.2B | 3.3B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 203.3M | 379.9M | 15.3M | 166.7M | 24.8M |
Total Current Liabilities | 16.1B | 31.7B | 14.3B | 12.7B | 12.3B |
Non-Current Liabilities | |||||
Long-term Debt | 23.1B | 9.9B | 7.5B | 10.3B | 12.0B |
Deferred Tax Liabilities | 4.4B | 4.3B | 4.1B | 3.8B | 2.9B |
Other Non-Current Liabilities | - | - | - | - | 700.0K |
Total Non-Current Liabilities | 29.1B | 15.6B | 29.1B | 36.1B | 32.0B |
Total Liabilities | 45.2B | 47.3B | 43.3B | 48.8B | 44.4B |
Equity | |||||
Common Stock | 7.5B | 7.5B | 7.5B | 7.5B | 7.5B |
Retained Earnings | 6.5B | -6.0B | -10.1B | -20.8B | -21.8B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 91.7B | 85.6B | 81.0B | 70.1B | 67.2B |
Key Metrics | |||||
Total Debt | 24.8B | 11.6B | 9.3B | 12.5B | 15.3B |
Working Capital | -1.4B | -17.5B | -195.3M | -1.4B | -2.0B |
Balance Sheet Composition
Fortis Healthcare Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 10.1B | 8.6B | 8.1B | 9.9B | 433.0M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | 0 | -9.4M |
Working Capital Changes | -2.1B | -322.8M | -1.3B | -1.5B | -19.6M |
Operating Cash Flow | 10.2B | 9.1B | 7.2B | 6.5B | 1.6B |
Investing Activities | |||||
Capital Expenditures | -8.3B | -9.3B | -4.4B | -1.2B | -2.1B |
Acquisitions | 0 | 647.9M | -124.9M | -3.2B | -10.5M |
Investment Purchases | -1.0B | -2.5B | -1.2B | -1.1B | - |
Investment Sales | 992.5M | 1.1B | 1.7B | 0 | 78.6M |
Investing Cash Flow | -8.4B | -9.2B | -4.0B | -5.5B | -2.0B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -1.1B | -860.3M | -159.8M | - | - |
Debt Issuance | 15.6B | 6.1B | 2.4B | 3.1B | 3.4B |
Debt Repayment | -2.0B | -4.3B | -5.2B | -6.5B | -2.9B |
Financing Cash Flow | -5.2B | 955.9M | -3.8B | -3.8B | -8.7M |
Free Cash Flow | 5.8B | 1.6B | 3.8B | 6.5B | 2.7B |
Net Change in Cash | -3.5B | 853.1M | -700.0M | -2.9B | -425.4M |
Cash Flow Trend
Fortis Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
78.10
Forward P/E
70.05
Price to Book
7.60
Price to Sales
8.37
PEG Ratio
70.05
Profitability Ratios
Profit Margin
10.73%
Operating Margin
17.96%
Return on Equity
8.44%
Return on Assets
5.65%
Financial Health
Current Ratio
0.92
Debt to Equity
26.99
Beta
0.61
Per Share Data
EPS (TTM)
₹11.49
Book Value per Share
₹118.11
Revenue per Share
₹107.21
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
fortis | 677.5B | 78.10 | 7.60 | 8.44% | 10.73% | 26.99 |
Max Healthcare | 1.2T | 115.26 | 13.09 | 12.10% | 15.31% | 32.09 |
Apollo Hospitals | 1.0T | 72.09 | 12.70 | 18.85% | 6.63% | 90.89 |
Global Health | 372.6B | 69.59 | 11.01 | 15.30% | 13.04% | 21.19 |
Narayana Hrudayalaya | 358.6B | 45.78 | 9.89 | 21.78% | 13.82% | 66.93 |
Aster DM Healthcare | 302.1B | 92.34 | 8.47 | 147.28% | 7.55% | 55.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.